Fitness and cognition in the elderly
The Austrian Stroke Prevention Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 13, 2015
- Accepted in final form August 10, 2015
- First Published January 6, 2016.
Article Versions
- Previous version (January 6, 2016 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Paul Freudenberger, MSc,
- Katja Petrovic, MSc,
- Abhijit Sen, PhD,
- Anna Maria Töglhofer, MSc,
- André Fixa, MD,
- Edith Hofer, PhD,
- Sabine Perl, MD,
- Robert Zweiker, MD,
- Sudha Seshadri, MD,
- Reinhold Schmidt, MD and
- Helena Schmidt, MD, PhD
- Paul Freudenberger, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Katja Petrovic, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Abhijit Sen, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The study was funded by the PhD Program Neurosciences of the Medical University of Graz, by funds from the Oesterreichische Nationalbank (Anniversary Fund, project 15435)
1. Employed by Medical University of Graz, Austria from the year 02/2011-01/2014.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anna Maria Töglhofer, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- André Fixa, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Edith Hofer, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sabine Perl, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Zweiker, MD,
AstraZeneca (commercial) Boehringer (commercial) Lilly (commercial) medmedia (commercial)
Menarini (invitation to convention) Biotronik (invitation to convention)
speaker honoraria: Daiichi, AstraZeneca, Genericon, Novartis, Menarini, MerckSharpDohme, Servier
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Novartis, Sanofi (PI of multicenter studies)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sudha Seshadri, MD,
NONE
NONE
NONE
Journal of Alzheimer's Disease, Associate Editor since 2005. Stroke: Editorial Board since 2010. Neurology: Editorial Board since 2011.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIA AG008122, AG033040, AG049505, AG033193, AG049607
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Reinhold Schmidt, MD and
Rivastigmin Patch, 2010, Novartis JSW Life Sciences 2010, Advisory Board for Dementia Trial Axon Neuroscience 2013 2014, 2015
NONE
Received travel expenses and/or honoraria for lectures from Pfizer (2004-2010), Novartis (2003-2010), Merz Austria (2005-2010) and Lundbeck (2004-2009) and for educational activity from Takeda 2010, Axon Neuroscience 2015
Editoral board member of Clinical Neurology and Neurosurgery 2004-currently
NONE
NONE
Pfizer 2004-2010,lectures Novartis 2003-2010,2014 lectures Merz Austria 2005-2010, lectures Lundbeck 2004-2009, lectures Takeda, 2010, teaching course
QPS, Austria Axon Neuroscience
NONE
NONE
NONE
NONE
Austrian Science Fund projects P20103 and I904
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Helena Schmidt, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Austrian Science Fund (FWF) P15454 2008-2011 Medical University Graz PHD Program BRAIN-Aging 2010-2014 Austrian National Bank Anniversary Fund P3388 2013-2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Institute of Molecular Biology and Biochemistry, Center for Molecular Medicine (P.F., A.M.T., A.F., H.S.), Department of Neurology (K.P., E.H., R.S., H.S.), Institute for Medical Informatics, Statistics and Documentation (E.H.), and Department of Cardiology (S.P., R.Z.), Medical University of Graz, Austria; Department of Public Health and General Practice (A.S.), Faculty of Medicine, Norwegian University of Science and Technology, Norway; and Department of Neurology (S.S.), Boston University School of Medicine, MA.
- Correspondence to Dr. Helena Schmidt: helena.schmidt{at}medunigraz.at
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan